Singapore markets close in 7 hours 37 minutes

Natera, Inc. (NTRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
69.76-0.65 (-0.92%)
At close: 04:00PM EST
70.50 +0.74 (+1.06%)
After hours: 07:02PM EST
Full screen
Trade prices are not sourced from all markets
Previous close70.41
Open70.41
Bid68.04 x 800
Ask71.49 x 900
Day's range69.14 - 70.91
52-week range36.90 - 71.29
Volume780,980
Avg. volume1,390,506
Market cap8.382B
Beta (5Y monthly)1.34
PE ratio (TTM)N/A
EPS (TTM)-4.51
Earnings date28 Feb 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est77.59
  • Business Wire

    Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call

    AUSTIN, Texas, February 20, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its fourth quarter and year ended December 31, 2023, after the market close on Feb. 28, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).

  • GuruFocus.com

    Natera Inc Director Herm Rosenman Sells 93,901 Shares

    Herm Rosenman, a director at Natera Inc (NASDAQ:NTRA), sold 93,901 shares of the company on February 16, 2024, according to a recent SEC Filing.

  • Business Wire

    New Study Validates Signatera™ in Endometrial Cancer

    AUSTIN, Texas, February 05, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in Gynecologic Oncology validating its personalized and tumor-informed molecular residual disease (MRD) test, Signatera, in endometrial cancer. The full study can be found here.